ArticleAnnals of the rheumatic diseases2021

JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib.

Paqui G Traves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.